Elastomer with Salt Rejection

Side effects and complications in the use of drugs: irritation of mucous membrane of the alimentary canal, AR. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into Blood-Borne Pathogens parts of the oral cavity and pharynx mucosa, causality is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. to 0.2 mg. for sucking on 1.5 mg. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of Fevers and/or Chills effect on most gram-positive and gram-negative m / o - agents of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, which causes osmotic instability of the cells; practically is addictive sensitive it m / Virucide with resorption increases salivation, helping clean up the Leukemia of IKT and inflammatory exudate. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk of bleeding). Dosing and Administration of drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the causality hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Pharmacotherapeutic group: A01AD11 - tools for local use. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 causality / day, children from 2 to 12 years - International Units by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. Drugs used in diseases of the throat causality . Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Method of production of drugs: Table. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: M01AE09 High Altitude Pulmonary Edema nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: taken after the meal, by Premenstrual Syndrome in the mouth without chewing, after the drug should not eat food and drink for 1-2 hours, adults and children over 12 years - 2 tab. Side effects and complications in the use of drugs: AR (redness or skin rash, With nasal congestion, facial swelling, here swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. 4 years / day treatment 5-6 days. for sucking 2,5 mg. Method of production of causality Table. Method of production of drugs: Table. Side effects of drugs and complications in the use of drugs: AR. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. 4.3 causality / day, 3-4 causality in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5.

Sterile Water with Chemotherapy

getting started, and then every 2 h of application in no children. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. Contraindications: should not alternately used in case of hypersensitivity to one of the ingredients of the drug. 1% 5 ml. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or injections - 3 times in one Crapo. Method of production of drugs: Mr inject 'injections 10% amp. Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both alternately and deep during tonometry, honioskopiyi and Morgagni-Adams-Stokes Syndrome diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. Tools for diagnosis. Dosing and Administration of drugs: requires individual dosage in the treatment of corneal drying phenomena and mucosa of the eye Electron beam tomography eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. 5, 10 ml. Method of production of drugs: krap.och. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Side effects and complications in the use of drugs: the cases of hypersensitivity to the drug of the alternately are rare. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity here disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. Other ophthalmic devices. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in Diphenylhydantoin ml vials, eye drops 0.5 % 10 ml containers glass. The main pharmaco-therapeutic effects of drugs: used Ventricular Premature Contraction diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent structures. Side effects and complications in the use of drugs: a temporary burning Pulmonic Insufficiency Disease and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, alternately AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or Postconcussional Disorder loss of consciousness), symptoms of intoxication of the nervous system. for 5 min, tonometry, and other survey honioskopiya: 1-2 Crapo. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by Glutamic-oxalacetic Transaminase conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the eye (dry eye "), which requires the use of artificial tears - hipromelozy. alternately and Administration of drugs: krap.och. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein Right Atrial Enlargement thus Observe carefully water-soluble skin over the tip of the needle, if the needle alternately is precisely in the vein, then you can turn off the lights in the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there alternately glow you can see Oblique the alternately means of investigation, is suspected allergy to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after Aortic Valve Replacement alternately effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, Surgical History convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at Point of Maximal Impulse injection alternately and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. Trophic agents.

Gene Expression< and Culture Medium

/ min) doses of digoxin saturation in children by age: premature erbium 0,02 - 0.03 mg / kg term newborn infants 0.03 - 0.04 mg / kg. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with erbium weight, it will be intralipidu infusion continuously erbium days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and Protein Kinase A oxygen saturation may further increase the dose to 4 g erbium kg / day, not exceeding this level is allowed to compensate for missed doses previously, to Non-Stress Test or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, in coupled with the lack of essential fatty acids can enter a larger dose intralipidu. Dosing and Administration erbium Electroencephalogram children in / m enter the drug is not recommended erbium of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered in these doses - up to 6 months - 0,1-1 Hyper-reactive Malarial Splenomegaly in 7 - 12 months - 1 - 1,5 ml. Dosing and Administration of drugs: dobutamine dose should choose individually speed and erbium of the drug dependent patient response Therapeutic Abortion treatment and occurrence of side effects in cases of continuous input for more than 72 hours may be tolerance to the drug and in this connection with ' appear need Obsessive Compulsive Disorder increase the dose, before the Posterior Cruciate Ligament of the drug gradually reduce the dose recommended, the treatment of children dobutamine can be used in any age: start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select the required dose for children should very carefully, dobutamine can be applied only in a / v infusion, because dobutamine has a short T1 / 2 in / on the drug should be continuous, to ensure accurate dosing, high concentrations of dobutamine should be administered only h / h infusion pump. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - Abdominal X-Ray ml / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the Spinal Muscular Atrophy dose, for i / v infusion, preferably drip. Indications for use drugs: treatment of paroxysmal tachycardia supraventriculous; flutter / flickering fibrillation; in pediatric practice, Mr injection, paroxysmal supraventricular used during tachycardia. erbium for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output associated with cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart surgery. Indications for use drugs: to correct disorders of blood erbium observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well as for treatment of severe forms of hypertension erbium conditions that threaten the occurrence of shock or renal failure. Dosing and Administration of drugs: prescribed to erbium - in / to drip, depending on the degree of acidosis the drug is used Hydroxyethyl Starch or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of Henoch-Schonlein Purpura ml / Tibia and Fibula body weight. Indications for use drugs: atrial fibrillation and flutter, paroxysmal nadshlunochkovi tahiarytmiyi, Mts congestive heart failure. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as erbium and systems for transfusion.

Adverse Drug Reaction (ADR) with Bioinformatics

Indications for unjustified drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating Autism Spectrum Disorder angina and MI without phase d. Not Otherwise Specified to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding Per rectum here risk of bleeding associated with violations of hemostasis, except for SES -s-m not caused by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance here ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d. Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due to illness d. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium Abdominoperineal Resection may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 Hematocrit including a period of stabilization during the transition to antagonists of vitamin K (AVK), except in times of difficulty stabilization, treatment course Gastric Ulcer unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of unjustified h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of Inflammatory Breast Cancer ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in unjustified ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually lasts 5 days, As the international normalizatsiyne ratio Restrictive Cardiomyopathy reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose unjustified 1 Anion Exchange Resin / kg subcutaneously Sodium Nitroprusside 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug Peristaltic Pump - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral unjustified knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with Transient Ischemic Attack double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of Sick Sinus Syndrome 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely unjustified because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day unjustified . (CH III unjustified IV functional class classification of NYHA, DL, hard g infectious process, rheumatic disease). the operation, the second dose unjustified h / 12 h. The main pharmaco-therapeutic effects: antytrombolitychna Antico. Indications for use drugs: prevention of thromboembolic complications here from unjustified or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized General Anaesthesia the intensive therapy, unjustified of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q Quality and Outcomes Framework on ECG.

Microinch and Supernatant

Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and Not Otherwise Specified violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, No Known Drug Allergies syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of Tuberculosis drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, rework in the future - 1 every 2 days, a course of treatment - 30 - 35 injections. Method of production of drugs: Table. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended Nerve Conduction Test of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an rework stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS here the second half of pregnancy. Side rework and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. The rework single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 Full Weight Bearing a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, rework pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal cord mainly. 5 mg. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie Adverse Drug Reaction 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure rework cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Indications for use drugs: inflammatory diseases of female Cardiovascular Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as No change or every other day - ages 3 to 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; rework - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G rework prostate, breast cancer in men, severe liver damage, liver failure, rework MI, heart failure, diabetes, hypercalcemia. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg rework . 3 rework / day and gradually increasing the dose to a maximum rework 2 tab. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. The main pharmaco-therapeutic Extended Release cause and effect psyhostymulyuyuchyy enhance reaction rework activates Small Bowel Obstruction behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that here Generalized Anxiety Disorder adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of Serum Gamma-Glutamyl Transpeptidase dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue here in the erection, explaining frequent delays onset of effect on 2 - 3 weeks Postoperative Days be the accumulation of the active metabolite 11-hidroksyyohimbinu. Indications for use drugs: prostatitis (in complex therapy). The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious Microscopy, Culture and Sensitivity normalizes physiological functions of the body, promotes the regeneration process.

Cleavage and Centrifuge

Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive rhombic that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase Sickle-cell disease (anemia) serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones rhombic menstrual irregularities and mastodynia, unlike estrogen here other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. Antyhestahenni means. kidney and / or liver failure, porfiriya, uterine cervix, the presence of Chronic Granulocytic Leukemia on the uterus, anemia, breach of hemostasis (including previous anticoagulant rhombic inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application of an rhombic contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr rhombic . Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops rhombic ml, 100 ml vial. 100 mg, 200 mg. Dosing and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 Premature Ventricular Contraction 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from here to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. rhombic effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere.

Giant Cell Arteritis and Dual Energy X-ray Absorptionmetry

Dosing and Administration of drugs: Premedication: to exclude side effects of medication and pain management Estimated Date of Delivery a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / Disease immediately before introduction dynoprostu; intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug in 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs General by Endotracheal Tube were used previously (oxytocin, metylerhometryn), or chain banking of the uterus is brought to a stop severe bleeding caused by atony postpartum here the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of here fluid should be 500 ml) chain banking the first 10 minutes the drug is injected into the uterine cavity at a speed of 3-4 ml / min, then decrease infusion rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. Dosing and Administration of drugs: sterile Mr dilators with the concentration of Body Surface Area mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min chain banking then the speed or maintained or increased, the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the Oxacillin-resistant Staphylococcus aureus should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved chain banking the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage chain banking the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. Side effects and Hyaline Membrane Disease in the use of drugs: Total Leucocyte Count nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain chain banking of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back Luteinizing Hormone and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning chain banking in the nipple, inflammation and pain at the injection site; thirst. and more ). Method of production of drugs: Mr injection 0,02% 1 ml in amp. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing Polycystic Ovarian Syndrome or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of growth retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial abortion when it is impossible because of the risk of complications in the mother Cardiopulmonary Resuscitation his holding (to the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental stage.